Skystar’s New Vaccine Facility in Huxian Passes Initial GMP Certification

[at noodls] – New Vaccine Facility Includes Animal and Aquaculture Vaccine Lines; At Maximum Potential Production Capacity, the New Facility Is Projected to Be Capable of Manufacturing an Estimated $15 Million to $17 … more

View todays social media effects on SKBI

View the latest stocks trending across Twitter. Click to view dashboard